Latest Blogs

Feb 24, 2017
Being fully present with her patients at work and with her family at home helps Dr. Jane Lowe Meisel be resilient and maintain her passion for oncology.
Feb 23, 2017
When the travel ban was announced, I worried for my patients and for my colleagues. I worried that medical care would be denied to international patients, including those who came to the U.S. for cancer care.
Feb 22, 2017
Making patients happy isn't just about doing whatever they ask. As health care professionals, we have an obligation to look out for their best interests.
Feb 21, 2017
During our national meetings, when we describe cases with CT scans and labs, why don’t we take the next step and inivite patients to tell their stories in their own words?
Subscribe to this column

Daniel F. Hayes, MD, FACP, FASCO

Daniel F. Hayes, MD, FACP, FASCO, is the 2016-2017 ASCO President. Dr. Hayes, a breast cancer specialist, is a Professor of Internal Medicine, the Stuart B. Padnos Professor in Breast Cancer, and the Clinical Director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center.

An ASCO member since 1986, Dr. Hayes has served the Society in numerous volunteer capacities. He is involved in several ASCO Expert Panels related to breast cancer. He served on the ASCO Board of Directors from 2011-2014, on the Conquer Cancer Foundation Grants Selection Committee, as Chair of the Scientific Program Committee, and on the Journal of Clinical Oncology Editorial Board. In 2007, he was presented with ASCO’s Gianni Bonadonna Breast Cancer Award and Lecture; in 2013, he was elected as a Fellow of ASCO (FASCO). Follow Dr. Hayes on Twitter @hoosierdfh.

Jan 05, 2017
Do you belong to your ASCO State/Regional Affiliate? If not, you should! Do you take advantage of all they have to offer? If not, you should! You, and more importantly your patients, will benefit enormously.
Dec 22, 2016
The advent of rapid and relatively affordable high-throughput molecular analyses has permitted the development of a bewildering next generation of new cancer diagnostic tests that are being introduced into clinical care using our grandparents’ regulatory structure.
Nov 28, 2016
Policy issues fundamentally affect us, our practices, and most importantly, our patients. As I hope you are aware, ASCO has our backs.  Indeed, understanding and making meaningful changes to health policy has become a major focus of ASCO.  
Oct 25, 2016
“When are we going to cure cancer?” If I had a dime for every time I’ve been asked that...The trite answer is that we already cure many cancers, just not enough of them! But the real question should be, “Why don’t we cure all cancers?”
Oct 18, 2016
Vice President Joe Biden and the government-wide Cancer Moonshot Task Force have presented today a sweeping vision that, if realized, could change the face of cancer prevention, screening, treatment, and survivorship as we know it.
Aug 24, 2016
Support for federal research funding for cancer is not about politics. It's about people. There is no one in our society—liberal, conservative, libertarian, or just don’t care—who isn’t touched in some way by cancer.

Pages